Nutex Health effects 1-for-15 reverse stock split; trading on split-adjusted basis from April 10

Nutex Health Inc.

Board approved 1-for-15 reverse split effective April 9, 2024 after filing Certificate of Amendment with Delaware.
No fractional shares issued; stockholders receive one whole share for any fractional interest.
Authorized shares unchanged at 950 million; par value $0.001 per share; new CUSIP 67079U207.
Common stock trades under symbol NUTX on Nasdaq beginning April 10, 2024 on post-split basis.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Nutex Health Inc.: Certificate of Amendment effecting a 1-for-15 reverse stock split of common stock (effective 2024-04-09).

Change: charter amendment
Effective: 2024-04-09

Exact text from the filing

On April 9, 2024, the Company filed the Certificate of Amendment with the Delaware Secretary of State to effect the Reverse Split, effective at 11:59 p.m. Eastern Time on April 9, 2024

View on SEC.gov

Browse all governance changes →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-004950

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.